BSECompany Update2d ago · 16 Nov 2026, 06:53 pm
Intimation of Investor Meet
Natco Pharma Ltd · 524816
✦ AI SummaryMgmt Change
Natco Pharma Ltd has announced an investor meet on November 19, 2026, in Pune, where company officials will interact with investors. The meeting schedule is subject to change due to exigencies. No unpublished price-sensitive information will be discussed during the interactions.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Attachments (1)
📄pdf
Download →
23ff5ca2-8d38-4104-a7c6-6d37e37aa37e.pdf
View document text
16th November, 2026
Corporate Relationship Department Manager – Listing
M/s. BSE Ltd. M/s. National Stock Exchange of India Ltd
Mumbai 400 001 Mumbai 400 051
Scrip Code: 524816 Scrip Code: NATCOPHARM
Dear Sir/Madam,
Sub: Intimation of Schedule of Investors Meet
Ref: Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and
Disclosure Requirements) Regulations, 2015 (“Listing Regulations”)
Pursuant to Regulation 30(6) read with Para A of Part A of Schedule III of the Listing Regulations,
this is to inform you that the officials of the company will be participating in the following
investor meeting:
Date of Investor / Meeting
Time Type of meeting Location
meeting name
19th November 9:00 AM to 2:00 In-person and
Investec Confluence Pune
2026 PM group
The schedule of the above-mentioned meeting is subject to change, and the change may occur
due to exigencies on the part of Investor / Company.
No Unpublished Price Sensitive Information (UPSI) pertaining to the Company is intended to be
discussed during the interactions.
Kindly take the same on record.
Thanking you
Yours faithfully
For NATCO Pharma Limited
Ch. Venkat Ramesh
Company Secretary &
Compliance Officer